The recent epidemics of metabolic diseases, obesity, type 2 diabetes (T2D), liver lipid
disorders and metabolic syndrome have largely been attributed to genetic background and …

Bisphenol A (BPA) is suspected to be associated with several chronic metabolic diseases.
The aim of the present study was to review the epidemiological literature on the relation …

In 2015, EFSA established a temporary tolerable daily intake (t‐TDI) for BPA of 4 μg/kg body
weight (bw) per day. In 2016, the European Commission mandated EFSA to re‐evaluate the …

The growing accumulation of microplastics (MPs) in aquatic environments is a global
concern. MPs are capable to interact with other environmental contaminants, including …

Context: Obesity and diabetes are epidemic in the European Union (EU). Exposure to
endocrine-disrupting chemicals (EDCs) is increasingly recognized as a contributor …

Epidemiological and animal studies indicate that increased exposure to bisphenol A (BPA)
induces various human cardiovascular diseases (CVDs), including myocardial infarction …

Bisphenols, as synthetic chemicals, have been widely detected in environmental and human
samples. Epidemiological studies have reported relationships between bisphenol A (BPA) …

Bisphenol A (BPA) is an endocrine disruptor with an oestrogenic activity that is widely
produced for the manufacture of polycarbonate plastic, epoxy resin, and thermal paper. Its …

Abstract Alternatives to Bisphenol A (BPA), such as BPF and BPAF, have found increasing
industrial applications. However, toxicological research on these BPA analogues remains …

Bisphenol A (BPA) is a representative endocrine disrupting compound used in a vast array
of consumer products, and are being frequently substituted by its analogues, bisphenol S …